Science Explorer Back to mapMap
Discussion
Company · Bologna · Italy

Alfasigma (Italy)

alfasigma.com/enROR OpenAlex
Research works
35
▲ 3% vs 2018-21
Citations
420
12.0 per fractional work
Top-10% rate
11.3%
all institutions 10.0%
Open access
62%
world 40%
International
27%
world 18%
Alfasigma (Italy)

Not ranked overall: Alfasigma (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Alfasigma (Italy) work in?

In all years, 51% of research at Alfasigma (Italy) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (50%), Biochemistry, Genetics and Molecular Biology (21%), Chemistry (4%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 18 fractional works · 51.2% of its workMedicine: 17 fractional works · 49.5% of its workOncology: 2 fractional works · 4.8% of its workSurgery: 1 fractional works · 4.0% of its workRheumatology: 1 fractional works · 3.6% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.5% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 3.5% of its workEpidemiology: 1 fractional works · 3.5% of its workGenetics: 1 fractional works · 3.2% of its workHepatology: 1 fractional works · 3.1% of its workOphthalmology: 1 fractional works · 2.5% of its workPharmacology: 1 fractional works · 2.3% of its workInternal Medicine: 1 fractional works · 2.1% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.9% of its workGastroenterology: 1 fractional works · 1.8% of its workHematology: 1 fractional works · 1.6% of its workNeurology: 1 fractional works · 1.6% of its workPhysiology: 1 fractional works · 1.5% of its workInfectious Diseases: 0 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.2% of its workComplementary and alternative medicine: 0 fractional works · 0.8% of its workEmergency Medicine: 0 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.5% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.8% of its workPeriodontics: 0 fractional works · 0.8% of its workHealth Professions: 0 fractional works · 0.6% of its workSpeech and Hearing: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workLife Sciences: 12 fractional works · 34.1% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 20.5% of its workMolecular Biology: 4 fractional works · 12.4% of its workCell Biology: 1 fractional works · 3.8% of its workGenetics: 1 fractional works · 1.9% of its workBiotechnology: 0 fractional works · 1.4% of its workClinical Biochemistry: 0 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 4.4% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.0% of its workCognitive Neuroscience: 0 fractional works · 0.9% of its workBiological Psychiatry: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.4% of its workBehavioral Neuroscience: 0 fractional works · 0.2% of its workDevelopmental Neuroscience: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 3.5% of its workFood Science: 1 fractional works · 3.2% of its workPlant Science: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 3.5% of its workImmunology: 1 fractional works · 3.3% of its workMicrobiology: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.2% of its workPharmaceutical Science: 0 fractional works · 1.3% of its workPharmacology: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 4 fractional works · 12.2% of its workChemistry: 2 fractional works · 4.4% of its workOrganic Chemistry: 1 fractional works · 3.0% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.7% of its workInorganic Chemistry: 0 fractional works · 0.5% of its workSpectroscopy: 0 fractional works · 0.2% of its workEngineering: 1 fractional works · 2.6% of its workBiomedical Engineering: 1 fractional works · 1.5% of its workAerospace Engineering: 0 fractional works · 0.5% of its workAutomotive Engineering: 0 fractional works · 0.3% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 1 fractional works · 2.2% of its workPolymers and Plastics: 0 fractional works · 0.9% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.5% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workBiomaterials: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 1.5% of its workComputer Science Applications: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.9% of its workEcology: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemical Engineering: 0 fractional works · 0.5% of its workProcess Chemistry and Technology: 0 fractional works · 0.5% of its workSocial Sciences: 1 fractional works · 2.4% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.9% of its workEconomics and Econometrics: 1 fractional works · 1.9% of its workPsychology: 0 fractional works · 0.3% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.2% of its workALL ITS WORKAlfasigma (Italy)35fractional works, all years
Life Sciences34%Physical Sciences12%Health Sciences51%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine1749.5%
    2. Dentistry00.8%
    3. Health Professions00.6%
    4. Nursing00.3%
    1. Biochemistry, Genetics and Molecular Biology720.5%
    2. Neuroscience24.4%
    3. Agricultural and Biological Sciences13.5%
    4. Immunology and Microbiology13.5%
    5. Pharmacology, Toxicology and Pharmaceutics12.2%
    1. Chemistry24.4%
    2. Engineering12.6%
    3. Materials Science12.2%
    4. Computer Science11.5%
    5. Environmental Science00.9%
    6. Chemical Engineering00.5%
    1. Economics, Econometrics and Finance11.9%
    2. Psychology00.3%
    3. Decision Sciences00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.19× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.58× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 2.99× its world share, 0 worksImmunology and Micro…Neuroscience: 3.31× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.06× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.02× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEngineering: 0.21× its world share, 0 worksEngineeringEnvironmental Science: 0.21× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.22× its world share, 1 worksMaterials ScienceDentistry: 3.63× its world share, 0 worksDentistryHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 2.39× its world share, 7 worksMedicineNursing: 1.44× its world share, 0 worksNursingDecision Sciences: 0.49× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.97× its world share, 1 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.1×. Every wedge is a field page.

All 16 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics5.06×0 works
  2. Dentistry3.63×0 works
  3. Biochemistry, Genetics and Molecular Biology3.58×3 works
  4. Neuroscience3.31×1 works
  5. Immunology and Microbiology2.99×0 works
  6. Medicine2.39×7 works
  7. Chemistry2.02×0 works
  8. Economics, Econometrics and Finance1.97×1 works
  9. Nursing1.44×0 works
  10. Materials Science1.22×1 works
  11. Agricultural and Biological Sciences1.19×1 works
  12. Decision Sciences0.49×0 works
  13. Engineering0.21×0 works
  14. Environmental Science0.21×0 works
  15. Health Professions0.07×0 works
  16. Computer Science0.03×0 works

Who are the top researchers at Alfasigma (Italy)?

Ranked on the quality score, Sara Soldi lead among researchers whose main affiliation is Alfasigma (Italy).

  1. 1 Sara Soldi Italy · #1,536,776 worldwide 932 citations · 29 works
All ranked researchers at Alfasigma (Italy)

What are the most cited papers from Alfasigma (Italy)?

The most cited paper from Alfasigma (Italy) is "Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy" (Mónica Galli, Manik Chatterjee, Mariella Grasso et al., 2018), with 117 citations. Next come "Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes" (92) and "Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention" (53).

Most cited papers
#PaperReleasedCitations
1 Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy Mónica Galli, Manik Chatterjee, Mariella Grasso et al. · Haematologica Open access 26 Apr 2018 117
2 Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes Michele Coluccia, Valeria Parisse, Paolo Guglielmi et al. · European Journal of Medicinal Chemistry Open access 3 Oct 2022 92
3 Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention Rocchina Colucci, Carolina Pellegrini, Matteo Fornai et al. · Frontiers in Pharmacology Open access 29 Nov 2018 53
4 Depression disorder in patients with cerebellar damage: Awareness of the mood state. Silvia Clausi, Michela Lupo, Giusy Olivito et al. · Journal of Affective Disorders 6 Nov 2018 53
5 Comparison of the Antithrombotic and Haemorrhagic Effects of Heparin and a New Low Molecular Weight Heparin in Rats G. Andriuoli, Roberto Mastacchi, Marco Barbanti et al. · Haemostasis 21 Apr 2009 50
All 63 most cited papers, with filters and sorting

Which keywords describe research at Alfasigma (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Diagnosis, Treatment, Synaptic Plasticity, Epidemiology, Monoclonal Antibodies, Angiogenesis and Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Inflammation3▲ 4.0×12 topics
  2. Epidemiology3▲ 2.1×19 topics
  3. Treatment2▲ 4.8×10 topics
  4. Diagnosis2▲ 5.7×10 topics
  5. Cancer2▲ 3.8×8 topics
  6. Synaptic Plasticity2▲ 16×3 topics
  7. Monoclonal Antibodies2▲ 30×3 topics
  8. Risk Factors2▲ 4.0×5 topics
  9. Angiogenesis1▲ 9.9×4 topics
  10. Immunotherapy1▲ 6.0×6 topics
  11. Oxidative Stress1▲ 2.2×10 topics
  12. Cancer Therapy1▲ 5.2×8 topics
  13. Cardiovascular Risk1▲ 9.4×3 topics
  14. Chemotherapy1▲ 4.7×5 topics
  15. Clinical Trials1▲ 5.6×4 topics
  16. Glycosylation1▲ 16×2 topics
  17. Hyaluronan1▲ 125×1 topic
  18. Nanoparticles1▲ 2.5×5 topics
  19. Proteoglycans1▲ 125×1 topic
  20. Toll-like Receptors1▲ 21×2 topics
  21. Antithrombotic Therapy1▲ 29×2 topics
  22. Microbiota1▲ 14×2 topics
  23. Probiotics1▲ 13×2 topics
  24. Obesity1▲ 4.0×3 topics

Which research topics does Alfasigma (Italy) publish most on?

By volume in 2022-now: Probiotics and Fermented Foods, Rheumatoid Arthritis Research and Therapies, Liver Disease and Transplantation and Gut microbiota and health.

Probiotics and Fermented…1Probiotics and Fermented Foods: 1 fractional worksRheumatoid Arthritis Res…1Rheumatoid Arthritis Research and Therapies: 1 fractional worksLiver Disease and Transp…0Liver Disease and Transplantation: 0 fractional worksGut microbiota and health0Gut microbiota and health: 0 fractional worksSpondyloarthritis Studies and Treatments: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksInflammatory Bowel Disease0Inflammatory Bowel Disease: 0 fractional worksTravel-related health issues: 0 fractional worksPharmaceutical Economics and Policy: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional works
Food ScienceRheumatologyHepatologyMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Probiotics and Fermented Foods Food Science 1 works
  2. 2 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  3. 3 Liver Disease and Transplantation Hepatology 0 works
  4. 4 Gut microbiota and health Molecular Biology 0 works
  5. 5 Spondyloarthritis Studies and Treatments Rheumatology 0 works
  6. 6 Biosimilars and Bioanalytical Methods Immunology 0 works
  7. 7 Inflammatory Bowel Disease Genetics 0 works
  8. 8 Travel-related health issues Public Health, Environmental and Occupational Health 0 works
  9. 9 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available62.2%not open37.8%

World: 40% of research is openly available.

with international co-authors26.9%domestic only73.1%

World: 18% is written across borders.

How has Alfasigma (Italy)'s research output changed?

Output in 2022-2025 was 3% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Alfasigma (Italy) as a percentage of every work published that year, 0.000039% in 2024.

still counting0.00010%0.00020%Alfasigma (Italy)0.000080% in 20251990200020102020

Fractional works of Alfasigma (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bologna

All research institutions in Bologna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Alfasigma (Italy). Posts are plain text and can be reported.